Arstasis, a manufacturer of medical devices for cardiologists, interventional radiologists, has introduced AXERA Access Device in the US for implant-free Arstaotomy procedure.
The AXERA Access Device is a femoral artery access tool that creates a longer and shallower angle arteriotomy, the Arstaotomy, resulting in tissue-upon-tissue overlap through the artery.
Upon sheath removal at the end of the procedure, arterial pressure is decreased across this longer Arstaotomy channel intended to provide an environment for clot formation and rapid femoral artery hemostasis.
The AXERA Device’s Arstaotomy procedure requires only minimal manual compression to provide secure closure with no foreign body implants – eliminating the risk of infections and thromboembolic events related to a vascular implant.
The Arstaotomy procedure promotes rapid hemostasis resulting in patient comfort with decreased bed rest and quicker ambulation.
P&S Surgical Hospital practicing interventional cardiologist Greg Sampognaro said the new AXERA Device allows to gain femoral artery access, even in the more complicated patient subsets of the obese and those with heavily diseased vessels.